The American Diabetes Association's McCormick Place event was also a bit of a coming out party for North Chicago-based Abbott ...

For adult women with overweight or obesity and type 2 diabetes (T2D), replacing diet beverages (DBs) with water is associated ...

VX-880 stem cell therapy led to 92% reduction in insulin use, with 10 out of 12 patients eliminating injections entirely in a ...

Women with diabetes who were overweight or had obesity lost more weight and had greater odds of diabetes remission when swapping diet soda for water.

Breakthrough T1D, formerly JDRF, the leading global type 1 diabetes (T1D) research and advocacy organization, gathered with ...

For high-risk patients with type 2 diabetes, oral semaglutide reduced risk for major cardiovascular and ischemic limb-related ...

The safety profile of the therapy was found to be favourable, without any serious adverse events linked to the treatment.

Most in a small group of patients receiving a stem cell-based infusion no longer needed insulin, but the drug may not suit ...

All 3 doses of orforglipron superior to placebo with respect to primary end point of change in HbA1c from baseline to week 40.

CHICAGO -- Mifepristone (Korlym) reduced HbA1c levels in patients with inadequately controlled type 2 diabetes and ...

Semaglutide improved time spent in glycemic range, time below rate and reduced body weight with low rates of hypoglycemia ...